TGFB1 and melanoma: Busse and Keilholz reported increased levels of TGF-β in melanoma patients with disease progression, providing an optimal microenvironment for undisturbed tumor growth by promoting tumor cell motility, invasiveness and modulating tumor stroma and extracellular matrix (Busse and Keilholz, 2011).